Cannabis stocks were moving lower Monday morning after the Food and Drug
Administration suggested hemp-derived cannabidiol, or CBD, is mostly illegal.
What Happened
The farm bill signed by President Donald Trump last week designated
hemp as an agricultural crop.
Yet CBD oil is a drug ingredient and cannot be included in products without FDA approval.
"Selling unapproved products with unsubstantiated therapeutic claims is not only a violation of the law, but also can put
patients at risk, as these products have not been proven to be safe or effective," FDA Commissioner Scott Gottlieb said in a
statement.
Why It's Important
Parts of hemp are already safe as food ingredients in the FDA's view, including hemp seeds, hemp seed protein and hemp seed
oil.The FDA said these are safe for use in food products under the condition they are not marketed as a treatment for diseases.
What's Next
Cannabis stocks were trading as follows at the time of publication
Monday:
-
New Age Beverages Corp (NASDAQ: NBEV):
down 4.78 percent.
-
Aphria Inc (NYSE: APHA): up 13.81
percent.
-
Tilray Inc (NASDAQ: TLRY): down 3.62
percent.
-
Cronos Group Inc (NASDAQ: CRON): up
1.47 percent.
-
Aurora Cannabis Inc (NYSE: ACB): up 2.4
percent.
-
Canopy Growth Corp (NYSE: CGC): up 2.78
percent.
-
Pyxus International Inc (NYSE: PYX): up 1
percent.
Related Links:
Pot
Stocks, ETFs, Top News And Data From The Cannabis Industry This Week
Canadian
Government Releases Proposed Cannabis Edible Regulations
© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.